Xience stents elute which drug?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $24.99Unlock all

Enhance your skills for the Invasive Cardiology Test. Study with practice quizzes, flashcards, and detailed explanations. Prepare confidently and efficiently!

Multiple Choice

Xience stents elute which drug?

Explanation:
Xience stents are everolimus-eluting devices. Everolimus is a rapamycin analog that inhibits the mTOR pathway, reducing smooth muscle cell proliferation after stent placement and thus lowering restenosis risk. This distinguishes Xience from other drug-eluting stents that use sirolimus, zotarolimus, or paclitaxel. Sirolimus is an older mTOR inhibitor, zotarolimus is another mTOR inhibitor used in different stent platforms, and paclitaxel works by a different mechanism (microtubule stabilization). The everolimus-eluting design of Xience has been associated with favorable healing and restenosis outcomes compared with some older drug-eluting platforms.

Xience stents are everolimus-eluting devices. Everolimus is a rapamycin analog that inhibits the mTOR pathway, reducing smooth muscle cell proliferation after stent placement and thus lowering restenosis risk. This distinguishes Xience from other drug-eluting stents that use sirolimus, zotarolimus, or paclitaxel. Sirolimus is an older mTOR inhibitor, zotarolimus is another mTOR inhibitor used in different stent platforms, and paclitaxel works by a different mechanism (microtubule stabilization). The everolimus-eluting design of Xience has been associated with favorable healing and restenosis outcomes compared with some older drug-eluting platforms.

More Multiple Choice Questions
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy